Clinical Trial Update: A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating a single-dose pain therapy for Painful Diabetic Neuropathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Neuropathy

Drugs mentioned

• Single Dose Pain Therapy (investigational product)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Painful Diabetic Neuropathy | Phase 2 | Status: WITHDRAWN